Price raises bidding issues at hearing
WASHINGTON – Rep. Tom Price, R-Ga., pressed Kathleen King, director of the Government Accountability Office (GAO), to explain CMS’s conclusion that the competitive bidding program has had no negative impact on beneficiaries during an April 30 Ways and Means Health Subcommittee hearing on waste, fraud and abuse. The GAO released a report on the program April 18 that drew its conclusions largely on information provided by CMS. During his questioning, Price learned that CMS had not conducted clinical data reviews and that the agency only tracked patient progress for 120 days, according to a bulletin from The VGM Group. “He also talked about the COPD foundation release, and wanted more information about patient care,” said Jay Witter, vice president of government affairs for AAHomecare, which had a representative at the meeting. To view Price at the hearing, click here.